FASEBPubs

Connecting scientists through FASEB Publications—home to The FASEB Journal & FASEB BioAdvances. By scientists, for scientists. Part of @FASEBorg. 📚🔬

[FASEB @FASEBorg]

The dismissal of the entire National Science Board further destabilizes NSF at a time of funding cuts, staffing reductions, and leadership vacancies. FASEB urges Congress and the Administration to restore a fully functioning NSB and protect the integrity of U.S. science leadership. Read our full statement: https://t.co/CPxAyjQTs3

[FASEBPubs @FASEBPubs]

New editorial from Loren E. Wold (@woldloren), Elizabeth A. Jonas & Thomas H. Sanderson explores FASEB’s new Generative AI policy for scholarly publishing.

Transparency. Accountability. Human oversight. Scientific rigor.

AI can support science — but not replace scientific responsibility. Read the editorial: https://t.co/pKejQgGxRn

[FASEBPubs @FASEBPubs]

What happens to research when results don’t support the hypothesis?

Too often—it never gets published.

We’re changing that. Learn how to publish null findings (with real examples) in the latest FASEB Publications newsletter from LinkedIn: https://t.co/vIwZtixtBM

[FASEBPubs @FASEBPubs]

New research in The FASEB Journal shows activating the smoothened receptor may reduce brain swelling, inflammation, and neurological damage after traumatic brain injury. Promising step toward targeted TBI treatments. 🔗 https://t.co/4IL7nSRGr4

[FASEBPubs @FASEBPubs]

Publishing with The FASEB Journal means more than sharing results—it means supporting science.
As a nonprofit journal, all revenue is reinvested into research, training, advocacy, and the scientific community.
🔗 Why publish with us: https://t.co/NsDWWHwBRl

[FASEBPubs @FASEBPubs]

What role does your body’s internal clock play in kidney disease?
This FASEB BioAdvances study shows how disrupted circadian rhythms may drive changes in metabolism in diabetic nephropathy.

Read the open access article:
https://t.co/hUOiZ6pz0y

[FASEBPubs @FASEBPubs]

What’s really happening in acne at the cellular level?

This study in FASEB BioAdvances identifies key skin cell (keratinocyte) biomarkers driving inflammation—and points to potential new treatment targets: https://t.co/z3iWNywm9D

[FASEBPubs @FASEBPubs]

Can new tech replace animal research? Not quite.

This Perspective in FASEB BioAdvances explains why animal models are still essential for understanding disease & developing treatments—and how they work alongside tools like AI and organ-on-chip models.

👉 https://t.co/hOh0lnKdy4

[woldl @woldloren]

Work hard, play hard!

[FASEBPubs @FASEBPubs]

A fantastic day at Stanford for The FASEB Journal’s Integrative Bioscience Symposium.

🏆 EIC @woldloren presenting a plaque to Nobel Laureate Carolyn Bertozzi
🧬 Outstanding science from our speakers & Associate Editors
👏 Great turnout + great discussions

Science in action. #FASEB #BiomedicalResearch #SciComm

[FASEBPubs @FASEBPubs]

Who are the cool scientists behind The FASEB Journal? 👀

Editor-in-Chief @woldloren, Deputy Editor Liz Jonas, and Associate Editors Stephen Hewitt, Lauren Sparks, and @kistanford6 kicked off a weekend in Stanford with dinner before a big few days ahead.

Today: our Symposium.
Tomorrow: an all-day strategy meeting focused on one thing — serving our authors and readers even better.

It’s not just publishing. It’s partnership.

[FASEBPubs @FASEBPubs]

Happening this week 👇

📅 Mar 6 | Stanford
🎤 Carolyn Bertozzi keynote
🧪 Cutting-edge biomedical research talks
👥 Only 60 attendees

Register now → https://t.co/gvTe5dWaBT

[FASEB @FASEBorg]

📢 Early-career researchers! Are you ready to shape the future of biosciences, not only in the lab but also in leadership? FASEB is reserving 3 voting seats on our Board & Science Policy Committee. This is your opportunity to bring your perspective directly into high‑level decisions that impact the biological and biomedical research community. Submit your application ➡️https://t.co/h7VjjfDRRT

[Hao Yin @HaoYin20]

YAP/TAZ as direct targets of Sirt6 deacetylase activity

Sirt6 ⏬YAP/TAZ-TEAD1 interaction ⏫VGLL4 (YAP/TAZ suppressor)-TEAD1 interaction

Both Lrat-Cre #HepaticStellateCell & Albumin-Cre Hepatocyte (or its Cre leaks to HSC?🤔) KO of Sirt6 ⏫Liver Fibrosis in MASH🐭 +HFCC diet

@KushanChowdhury @FASEBPubs 2022
https://t.co/L9myJejEVE

[FASEBPubs @FASEBPubs]

Early-career faculty: don’t miss this.

📅 Mar 6 | Stanford
🎤 Keynote: Nobel Laureate Carolyn Bertozzi
🧬 From Molecules to Medicine Symposium
👥 Only 60 seats

Free registration → https://t.co/tTtTiSC5iG

[FASEBPubs @FASEBPubs]

Your research deserves to be seen.
The FASEB Journal publishes high-impact, rigorously reviewed research that reaches scientists, clinicians, and policymakers across disciplines.

Publish where your work has influence beyond the page.

🔗 Learn more: https://t.co/SUXTbg0Wyr

[NEI @NatEyeInstitute]

New #NIHFunded research offers hope for vision loss from #Stargardt disease (an inherited eye condition causing vision loss).
Scientists found that changing how the body uses vitamin A may help slow or reverse damage in mouse models.

https://t.co/RBQlXJKvi3

#ResearchNews

[FASEBPubs @FASEBPubs]

Science is better when shared — especially with you ❤️
Happy Valentine’s Day from FASEB Publications!
#ValentinesDay #ScienceCommunity

[Hao Yin @HaoYin20]

#Senescence

E2F7 is methylated & stabilized (shunted away from ubiquitination) by Protein Arginine Methyltransferase 1

Sirt6 as a direct anti-senescent target gene in Smooth Muscle Cell

@FASEBPubs 2025
https://t.co/zIBS4uFCsy

[FASEB @FASEBorg]

📢 Now published: the first article from FASEB’s ASNAM Initiative!
Authored by leading musculoskeletal researchers, it outlines why animal models remain essential to advancing musculoskeletal research amid growing use of alternative methods. Read the full article: https://t.co/PRxl3LZRjr

💡 In case you didn't know: FASEB’s Assessing Scientific Need for Animal Models (ASNAM) Initiative supports expert-driven perspectives that inform science policy with evidence. #FASEB #AnimalResearch